33263931|t|Exploring the molecular approach of COX and LOX in Alzheimer's and Parkinson's disorder.
33263931|a|Neuroinflammation is well established biomarker for the major neurodegenerative like Alzheimer's disease (AD) and Parkinson's disease (PD). Cytokines/chemokines excite phospholipase A2 and cyclooxygenases (COX), facilitating the release of arachidonic acid (AA) and docosahexaenoic acid (DHA) from membrane glycerophospholipids, in which the former is oxidized to produce pro-inflammatory eicosanoids (prostaglandins, leukotrienes and thromboxane's), which intensify the neuroinflammatory events in the brain. Similarly, resolvins and neuroprotectins are the metabolized products of docosahexaenoic acid, which exert an inhibitory effect on the production of eicosanoids. Furthermore, an oxidized product of arachidonic acid, lipoxin, is generated via 5-lipoxygenase (5-LOX) pathway, and contributes to the resolution of inflammation, along with anti-inflammatory actions. Moreover, DHA and its lipid mediators inhibit neuroinflammatory responses by blocking NF-kappaB, inhibiting eicosanoid production, preventing cytokine secretion and regulating leukocyte trafficking. Various epidemiological studies reported, elevated levels of COX-2 enzyme in patients with AD and PD, indicating its role in progression of the disease. Similarly, enhanced levels of 5-LOX and 12/15-LOX in PD models represent their role brain disorders, where the former is expressed in AD patients and the latter exhibits it involvement in PD. The present review elaborates the role of AA, DHA, eicosanoids and docosanoids, along with COX and LOX pathway which provides an opportunity to the researchers to understand the role of these lipid mediators in neurological disorders (AD and PD). The information gathered from the review will aid in facilitating the development of appropriate therapeutic options targeting COX and LOX pathway.
33263931	44	47	LOX	Gene	4015
33263931	51	87	Alzheimer's and Parkinson's disorder	Disease	MESH:D010300
33263931	89	106	Neuroinflammation	Disease	MESH:D000090862
33263931	151	168	neurodegenerative	Disease	MESH:D019636
33263931	174	193	Alzheimer's disease	Disease	MESH:D000544
33263931	195	197	AD	Disease	MESH:D000544
33263931	203	222	Parkinson's disease	Disease	MESH:D010300
33263931	224	226	PD	Disease	MESH:D010300
33263931	257	273	phospholipase A2	Gene	5319
33263931	329	345	arachidonic acid	Chemical	MESH:D016718
33263931	355	375	docosahexaenoic acid	Chemical	MESH:D004281
33263931	377	380	DHA	Chemical	MESH:D004281
33263931	396	416	glycerophospholipids	Chemical	MESH:D020404
33263931	465	477	inflammatory	Disease	MESH:D007249
33263931	478	489	eicosanoids	Chemical	MESH:D015777
33263931	491	505	prostaglandins	Chemical	MESH:D011453
33263931	507	519	leukotrienes	Chemical	MESH:D015289
33263931	524	537	thromboxane's	Chemical	MESH:D013931
33263931	560	577	neuroinflammatory	Disease	MESH:D000090862
33263931	610	619	resolvins	Chemical	-
33263931	624	639	neuroprotectins	Chemical	-
33263931	672	692	docosahexaenoic acid	Chemical	MESH:D004281
33263931	748	759	eicosanoids	Chemical	MESH:D015777
33263931	797	813	arachidonic acid	Chemical	MESH:D016718
33263931	815	822	lipoxin	Chemical	MESH:D044045
33263931	841	855	5-lipoxygenase	Gene	240
33263931	857	862	5-LOX	Gene	240
33263931	910	922	inflammation	Disease	MESH:D007249
33263931	940	952	inflammatory	Disease	MESH:D007249
33263931	972	975	DHA	Chemical	MESH:D004281
33263931	984	989	lipid	Chemical	MESH:D008055
33263931	1008	1025	neuroinflammatory	Disease	MESH:D000090862
33263931	1048	1057	NF-kappaB	Gene	4790
33263931	1070	1080	eicosanoid	Chemical	MESH:D015777
33263931	1222	1227	COX-2	Gene	4513
33263931	1238	1246	patients	Species	9606
33263931	1252	1254	AD	Disease	MESH:D000544
33263931	1259	1261	PD	Disease	MESH:D010300
33263931	1344	1349	5-LOX	Gene	240
33263931	1367	1369	PD	Disease	MESH:D010300
33263931	1398	1413	brain disorders	Disease	MESH:D001927
33263931	1448	1450	AD	Disease	MESH:D000544
33263931	1451	1459	patients	Species	9606
33263931	1502	1504	PD	Disease	MESH:D010300
33263931	1552	1555	DHA	Chemical	MESH:D004281
33263931	1557	1568	eicosanoids	Chemical	MESH:D015777
33263931	1573	1584	docosanoids	Chemical	-
33263931	1605	1608	LOX	Gene	4015
33263931	1698	1703	lipid	Chemical	MESH:D008055
33263931	1717	1739	neurological disorders	Disease	MESH:D009461
33263931	1741	1743	AD	Disease	MESH:D000544
33263931	1748	1750	PD	Disease	MESH:D010300
33263931	1888	1891	LOX	Gene	4015
33263931	Positive_Correlation	MESH:D013931	MESH:D000090862
33263931	Positive_Correlation	MESH:D015289	MESH:D000090862
33263931	Negative_Correlation	MESH:D008055	4790
33263931	Association	MESH:D000544	4015
33263931	Positive_Correlation	MESH:D004281	MESH:D013931
33263931	Positive_Correlation	MESH:D000544	4513
33263931	Association	MESH:D004281	MESH:D010300
33263931	Positive_Correlation	MESH:D015289	MESH:D007249
33263931	Negative_Correlation	MESH:D004281	MESH:D015777
33263931	Negative_Correlation	MESH:D008055	MESH:D000090862
33263931	Association	MESH:D044045	240
33263931	Association	MESH:D009461	4015
33263931	Association	MESH:D001927	240
33263931	Association	MESH:D000544	240
33263931	Association	MESH:D010300	4015
33263931	Positive_Correlation	MESH:D013931	MESH:D007249
33263931	Association	MESH:D000090862	4790
33263931	Association	MESH:D016718	240
33263931	Positive_Correlation	MESH:D015777	MESH:D000090862
33263931	Positive_Correlation	MESH:D011453	MESH:D000090862
33263931	Positive_Correlation	MESH:D010300	4513
33263931	Positive_Correlation	MESH:D004281	MESH:D015289
33263931	Association	MESH:D010300	240
33263931	Association	MESH:D008055	MESH:D009461
33263931	Negative_Correlation	MESH:D004281	4790
33263931	Negative_Correlation	MESH:D044045	MESH:D007249
33263931	Negative_Correlation	MESH:D004281	MESH:D000090862

